amfAR, The Foundation for AIDS Research

About TREAT Asia

TAMAP1
The location of TREAT Asia’s adult and pediatric network members

TREAT Asia (Therapeutics Research, Education, and AIDS Training in Asia) is a collaborative network of clinics, hospitals, research institutions, and civil society that is working to ensure the safe and effective delivery of HIV treatments to adults and children across the Asia-Pacific through researcheducation, and advocacy of evidence-based HIV-related policies. TREAT Asia’s unique capacity to bring together researchers, doctors, activists, advocates, and policymakers plays an important role in the region’s response to HIV, and it has become a model for regional collaboration on HIV/AIDS.

The Asia-Pacific region is home to nearly 60% of the world’s population and more HIV-positive people than any region outside sub-Saharan Africa. When TREAT Asia was founded in 2001, little attention was being paid to the looming AIDS crisis in the region. Substantial progress has since been made to develop comprehensive local, national, and regional responses to combat HIV, and the number of new infections in the region has decreased by approximately 20% and AIDS-related deaths by 30% since 2005. Access to antiretroviral therapy (ART) in the region has increased from 19% in 2010 to 41% in 2015.

However, challenges to turning the tide against AIDS in the Asia Pacific remain. Large numbers of people living with HIV still do not have access to ART and HIV-positive pregnant women in South Asia have particularly limited access to the antiretroviral medicines needed to prevent mother-to-child transmission (PMTCT) of HIV. In fact, the Asia Pacific region lags well behind certain regions in Africa in terms of ART and PMTCT coverage. In Pakistan AIDS-related deaths have more than doubled since 2005, and in Indonesia AIDS-related deaths are five times higher than they were in 2005. While the region has seen an overall decline in new infections, in several countries—including China, Indonesia, Pakistan, and the Philippines—rates of new infections are increasing. HIV rates among key populations—people who inject drugs (PWID), men who have sex with men (MSM), transgender individuals, and sex workers—are far higher than among the general population, and rising. For example, over 43% of PWID in Jakarta and over 28% of MSM in Bangkok are HIV positive. TREAT Asia and its network remain committed to overcoming these challenges through collaborative research, targeted provider training and community treatment literacy, and advocacy to improve access to treatment. 

 

Updated March 15, 2017